The prognostic significance of human equilibrative nucleoside transporter1 (hENT1) expression in metastatic bladder cancer patients treated with gemcitabine-cisplatin based combination chemotherapy
Systemic combination chemotherapy, such as the methotrexate, vinblastine, doxorubicin and cisplatin (MVAC) regimen, has shown certain activity in advanced bladder cancer, but is associated with a significant toxicity burden, with a treatment-related mortality of about 4%. Therefore, a great deal of...
| Veröffentlicht in: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 57(2011), 3 vom: 01. März, Seite 157-61 |
|---|---|
| 1. Verfasser: | |
| Weitere Verfasser: | |
| Format: | Aufsatz |
| Sprache: | Japanese |
| Veröffentlicht: |
2011
|
| Zugriff auf das übergeordnete Werk: | Hinyokika kiyo. Acta urologica Japonica |
| Schlagworte: | English Abstract Journal Article Antimetabolites, Antineoplastic Antineoplastic Agents Equilibrative Nucleoside Transporter 1 SLC29A1 protein, human Deoxycytidine 0W860991D6 Cisplatin Q20Q21Q62J |